Intellia Therapeutics (NTLA) Reports In-Line Q2 EPS

Go back to Intellia Therapeutics (NTLA) Reports In-Line Q2 EPS
(NASDAQ: NTLA) Delayed: 11.74 -0.19 (1.59%)
Previous Close $11.93    52 Week High $30.40 
Open $12.10    52 Week Low $11.86 
Day High $12.19    P/E N/A 
Day Low $11.69    EPS $0.00 
Volume 2,712,094